Book Appointments & Health Checkup Packages
Book Appointments & Health Checkup Packages
Patients of borderline ovarian tumours or non-epithelial tumours may be treated with fertility-sparing surgery. This method is applied for the treatment of ovarian cancer. The aim of Oncofertility sparing surgery is to ovarian tissue and the uterus. This surgery also improves sexual function and psychological well-being. Commonly both sexual and psychological well-being get affected after the diagnosis and treatment of cancer.
There are two types of ovarian cancer. These are epithelial and non-epithelial. To treat epithelial ovarian cancer, you will have to undergo radical surgery. But you may be recommended Fertility Sparing Surgery to treat non-epithelial ovarian cancer.
Clinical Outcomes of Fertility Sparing Surgery
Borderline ovarian tumours are common among younger women who are of childbearing age. The prognosis of BOT is considered to be excellent. The current BOT treatment includes total abdominal hysterectomy, omentectomy, and multiple peritoneal biopsies. Fertility Sparing Surgery helps to preserve the uterus and the part of the ovary. The global recurrence rate was related to the type of surgery. The risk is higher for patients undergoing cystectomy. Visit our cancer care hospital in Broadway for the best treatment
Women with BOT have a lower risk of relapse if treated with Fertility Sparing Surgery. The risk of relapse is lower for those treated with Fertility Sparing Surgery. Women with bilateral tumours undergo initial cystectomy. To preserve fertility, you may have to undergo another cystectomy in case of a relapse of BOT. In such a situation, the following procedures will be performed:
Magnetic Resonance Imaging (MRI) helps assess possible healthy functional ovarian tissue.
An oncofertility consultation helps with preoperative fertility preservation.
Survival of Patients
If recurrence happens after conducting Fertility Sparing Surgery, it can be managed by further surgery. It does not affect the survival rate. Recurrence is less frequent. Very few patients died when the surgery was conducted, and it was less lethal than radical surgery. There is a record of survival of patients undergoing cystectomy.
For Epithelial Ovarian Cancer
It isn't easy to analyse the outcome of Fertility Sparing Surgery. Many researchers have stated that Fertility Sparing Surgery can be offered to those with Stage I of Epithelial Ovarian cancer of any grade. Because some of the reported series mix with epithelial and non-epithelial ovarian cancers. In the case of Epithelial Ovarian Cancer, Fertility Sparing Surgery was offered for very few patients. The overall survival rate of 52 patients offered the surgery was 10 years. Book an appointment to have the best treatment.
Patients with BOT get good results when Fertility Sparing Surgery is applied. Therefore, the surgery is recommended among women interested in conceiving. ART can be used among patients with persistent infertility. Patients with Epithelial Ovarian Cancer should be considered adequately staged patients with stage IA. Therefore, it can be said that Fertility Sparing Surgery plays a vital role in the survival of patients with Non-epithelial Ovarian Cancer. Patient with Non-epithelial Ovarian Cancer can take the help of Fertility Sparing Surgery without any hesitation.
Experience world-class healthcare at Manipal Hospitals. Our expert team of doctors and state-of-the-art facilities ensure personalized and advanced treatments. Take the first step towards wellness. Book an appointment today.
Home Broadway Specialities Gynaec-oncology Onco-fertility-sparing-surgery